Azenta, Inc. provided earnings guidance for the full fiscal year 2024. The company expected revenue in the range of $659 million to $671 million, due to the timing of B Medical revenue.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
51.08 USD | +0.27% | -0.91% | -21.58% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.58% | 2.75B | |
+54.05% | 58.71B | |
-2.02% | 41.31B | |
+36.81% | 39.2B | |
-10.22% | 27.4B | |
+13.42% | 26.55B | |
-21.60% | 18.98B | |
+2.89% | 12.51B | |
+22.40% | 11.94B | |
+27.49% | 12.08B |
- Stock Market
- Equities
- AZTA Stock
- News Azenta, Inc.
- Azenta, Inc. Provides Earnings Guidance for the Full Fiscal Year 2024